is time to short and keep, this share will not keep continue high as now sure will drop back, if you miss the chance when went up now is time to keep short. Like what warren buffet said when people crazy you keep calm, when people calm you crazy.
$GameStop(GME.US$
$GameStop(GME.US$
5
2
Jlbs94
commented on
is a trap in this app? like have a backend logic when you buy up the price went down and vise versa. anyone have this feeling?
$Tesla(TSLA.US$
$Tesla(TSLA.US$
7
Jlbs94
liked and commented on
$iShares Russell 2000 ETF(IWM.US$
$Senseonics(SENS.US$
$Tesla(TSLA.US$
$Apple(AAPL.US$
$FULU HOLDINGS(02101.HK$
SENS is a medical technology company focused on developing and manufacturing long-term, implantable continuous blood sugar monitoring systems for diabetics. I have owned SENS since June 2021 until now, and I am optimistic about SENS products. Whether it rises or falls, it wants to make a profit when its next-generation products are approved.
On February 11, 2022, SENS received approval from the US Food and Drug Administration for the next generation Eversense E3CGM system. However, the stock price plummeted on the same day. Stocks that had been in business for a long time turned into losses, which really made people cry and laugh. Reflecting on the idea of operation, I realized that I still didn't establish a good operating system for stock profits, nor did I have a pre-formulated profit operation plan; of course, I didn't establish a take-profit or stop-loss plan; as a result, stocks that could have been profitable turned into losses. SENS also made me realize that being optimistic about a company doesn't mean holding at any cost; a good company is not necessarily a good investment target. Of course, you should even less follow the news to trade stocks; fantasize that the stock price will be...
$Senseonics(SENS.US$
$Tesla(TSLA.US$
$Apple(AAPL.US$
$FULU HOLDINGS(02101.HK$
SENS is a medical technology company focused on developing and manufacturing long-term, implantable continuous blood sugar monitoring systems for diabetics. I have owned SENS since June 2021 until now, and I am optimistic about SENS products. Whether it rises or falls, it wants to make a profit when its next-generation products are approved.
On February 11, 2022, SENS received approval from the US Food and Drug Administration for the next generation Eversense E3CGM system. However, the stock price plummeted on the same day. Stocks that had been in business for a long time turned into losses, which really made people cry and laugh. Reflecting on the idea of operation, I realized that I still didn't establish a good operating system for stock profits, nor did I have a pre-formulated profit operation plan; of course, I didn't establish a take-profit or stop-loss plan; as a result, stocks that could have been profitable turned into losses. SENS also made me realize that being optimistic about a company doesn't mean holding at any cost; a good company is not necessarily a good investment target. Of course, you should even less follow the news to trade stocks; fantasize that the stock price will be...
Translated
10
7